CD226 and gastric cancer: In the present study, we showed that the proportion of peripheral blood NK cells which expressed the activating receptors NKp30, NKp46, NKG2D, and DNAM-1 was significantly decreased in GC patients compared to healthy donors and also negatively correlated with GC progression.